FP
IPXL

Factorial Partners’s Impax Laboratories, Inc. IPXL Stock Holding History

Factorial Partners’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25,200
Closed -$420K – 112
2017
Q4 		$420K Buy
+25,200
New +$462K 0.39% 79

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Factorial Partners's IPXL Position: Q1 2018 in Review

Factorial Partners sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 25,200 shares — an estimated $420K sold.

Factorial Partners first reported a position in IPXL in Q4 2017 and held it in 1 quarter. The position peaked at $420K in Q4 2017. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

  • Factorial Partners reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
  • Factorial Partners sold 25,200 Impax Laboratories, Inc. shares in Q1 2018, an estimated $420K.
  • Factorial Partners first reported a position in Impax Laboratories, Inc. in Q4 2017 and held it in 1 quarter.
  • Factorial Partners's Impax Laboratories, Inc. position peaked at $420K in Q4 2017.
  • 188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Factorial Partners's 13F filing for Q1 2018, filed 23 Apr 2018.